STAAR Surgical Current Ratio 2010-2024 | STAA
STAAR Surgical current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| STAAR Surgical Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-09-30 |
$0.40B |
$0.07B |
5.99 |
| 2024-06-30 |
$0.38B |
$0.07B |
5.80 |
| 2024-03-31 |
$0.37B |
$0.06B |
5.84 |
| 2023-12-31 |
$0.37B |
$0.07B |
5.62 |
| 2023-09-30 |
$0.35B |
$0.06B |
6.11 |
| 2023-06-30 |
$0.33B |
$0.05B |
6.05 |
| 2023-03-31 |
$0.31B |
$0.05B |
6.65 |
| 2022-12-31 |
$0.31B |
$0.05B |
6.03 |
| 2022-09-30 |
$0.30B |
$0.05B |
6.55 |
| 2022-06-30 |
$0.30B |
$0.05B |
6.37 |
| 2022-03-31 |
$0.27B |
$0.04B |
6.65 |
| 2021-12-31 |
$0.27B |
$0.05B |
5.56 |
| 2021-09-30 |
$0.26B |
$0.05B |
5.64 |
| 2021-06-30 |
$0.25B |
$0.04B |
5.94 |
| 2021-03-31 |
$0.22B |
$0.04B |
6.19 |
| 2020-12-31 |
$0.22B |
$0.04B |
5.25 |
| 2020-09-30 |
$0.20B |
$0.03B |
5.79 |
| 2020-06-30 |
$0.18B |
$0.03B |
5.78 |
| 2020-03-31 |
$0.17B |
$0.03B |
5.76 |
| 2019-12-31 |
$0.18B |
$0.03B |
5.07 |
| 2019-09-30 |
$0.17B |
$0.03B |
5.50 |
| 2019-06-30 |
$0.16B |
$0.03B |
5.54 |
| 2019-03-31 |
$0.15B |
$0.03B |
5.41 |
| 2018-12-31 |
$0.15B |
$0.03B |
5.47 |
| 2018-09-30 |
$0.15B |
$0.03B |
5.35 |
| 2018-06-30 |
$0.07B |
$0.03B |
2.68 |
| 2018-03-31 |
$0.06B |
$0.03B |
2.43 |
| 2017-12-31 |
$0.05B |
$0.02B |
2.82 |
| 2017-09-30 |
$0.06B |
$0.03B |
2.24 |
| 2017-06-30 |
$0.05B |
$0.02B |
2.52 |
| 2017-03-31 |
$0.05B |
$0.02B |
2.25 |
| 2016-12-31 |
$0.05B |
$0.02B |
2.35 |
| 2016-09-30 |
$0.05B |
$0.02B |
2.34 |
| 2016-06-30 |
$0.05B |
$0.02B |
2.40 |
| 2016-03-31 |
$0.05B |
$0.02B |
2.57 |
| 2015-12-31 |
$0.05B |
$0.02B |
2.74 |
| 2015-09-30 |
$0.05B |
$0.02B |
2.85 |
| 2015-06-30 |
$0.05B |
$0.02B |
3.10 |
| 2015-03-31 |
$0.04B |
$0.02B |
2.86 |
| 2014-12-31 |
$0.05B |
$0.02B |
2.74 |
| 2014-09-30 |
$0.05B |
$0.02B |
2.91 |
| 2014-06-30 |
$0.05B |
$0.02B |
2.95 |
| 2014-03-31 |
$0.05B |
$0.02B |
2.79 |
| 2013-12-31 |
$0.05B |
$0.02B |
2.72 |
| 2013-09-30 |
$0.05B |
$0.02B |
2.91 |
| 2013-06-30 |
$0.04B |
$0.02B |
2.84 |
| 2013-03-31 |
$0.04B |
$0.02B |
2.74 |
| 2012-12-31 |
$0.04B |
$0.02B |
2.46 |
| 2012-09-30 |
$0.04B |
$0.01B |
2.94 |
| 2012-06-30 |
$0.04B |
$0.01B |
2.98 |
| 2012-03-31 |
$0.04B |
$0.01B |
3.08 |
| 2011-12-31 |
$0.04B |
$0.01B |
2.76 |
| 2011-09-30 |
$0.04B |
$0.01B |
2.79 |
| 2011-06-30 |
$0.03B |
$0.01B |
2.65 |
| 2011-03-31 |
$0.03B |
$0.01B |
2.49 |
| 2010-12-31 |
$0.03B |
$0.01B |
2.23 |
| 2010-09-30 |
$0.03B |
$0.01B |
2.19 |
| 2010-06-30 |
$0.03B |
$0.01B |
2.24 |
| 2010-03-31 |
$0.04B |
$0.02B |
2.06 |
| 2009-12-31 |
$0.04B |
$0.03B |
1.50 |
| 2009-09-30 |
$0.04B |
$0.02B |
1.84 |
| 2009-06-30 |
$0.04B |
$0.02B |
1.89 |
| 2009-03-31 |
$0.03B |
$0.03B |
1.22 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$1.231B |
$0.322B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
